Monitor for any reverse stock split or capital raise announcement as the most likely path to regain compliance before the April 12, 2027 deadline. The stock's continued decline below $1.00 increases the probability of a reverse split, which could create near-term volatility.
Price Chart
Executive Summary
Lucid Diagnostics received a Nasdaq deficiency notice on October 12, 2026, for failing to maintain a minimum $1.00 closing bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 calendar days (until April 12, 2027) to regain compliance by closing at or above $1.00 for at least 10 consecutive business days, and may be eligible for an additional 180-day cure period. Failure to cure could result in delisting, which would severely reduce institutional ownership and liquidity.
Key Facts
- Nasdaq deficiency notice received October 12, 2026 for bid price below $1.00 for 30 consecutive business days through October 9, 2026
- 180 calendar day compliance period ends April 12, 2027
- To regain compliance, closing bid price must be at least $1.00 for a minimum of 10 consecutive business days
- Company may be eligible for an additional 180-day cure period if it does not regain compliance within the initial period
- Common stock continues trading under symbol LUCD on Nasdaq Capital Market with no immediate effect on listing
- Company intends to consider all available options to regain compliance
Financial Impact
Delisting risk is binary and material — loss of Nasdaq listing would severely reduce institutional ownership and liquidity. No financial figures provided in the filing.
Risk Factors
- Failure to regain compliance within 180 days (or extended period) could lead to delisting from Nasdaq
- Potential reverse stock split may be necessary, which often carries negative signaling and short-term price pressure
- Continued low stock price may trigger further selling by institutional holders with minimum price requirements
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-047404 |
| Document: 0001493152-26-047404-index-headers.html | 0001493152-26-047404 |
| Document: 0001493152-26-047404-index.html | 0001493152-26-047404 |
| Document: 0001493152-26-047404.txt | 0001493152-26-047404 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.4110 $0.5007 | ▼ −21.82% | ▼ −21.11% | $0.5010 (−21.90%) |
Oct 16, 2026 10d ago | 8-K | $0.3770 $0.3520 | ▲ +6.63% | ▲ +6.97% | $0.5010 (−32.89%) |
Sep 22, 2026 4w ago | 8-K | $0.8930 $0.8390 | ▼ −6.05% | ▼ −5.33% | $0.5010 (−43.90%) |
Aug 13, 2026 10w ago | 8-K | $0.9649 $0.9677 | ▲ +0.29% | ▲ +0.49% | $0.5010 (−48.08%) |
May 14, 2026 23w ago | 8-K | $1.02 $0.9910 | ▲ +2.84% | ▲ +1.62% | $0.5010 (+50.88%) |
Apr 24, 2026 26w ago | 8-K | $1.06 $1.04 | ▼ −1.89% | ▼ −1.40% | $0.5010 (−52.74%) |
Apr 23, 2026 26w ago | 8-K | $1.07 $1.06 | ▼ −0.93% | ▼ −1.10% | $0.5010 (−53.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers